Program

July 1 (Wed)

Opening Remarks
Scientific Sessions (Lecture, Symposium, Workshop, Oral & Poster Session of Candidates for the Excellent Presentation Award, Poster Session of Candidates for the Student Poster Award and Oral & Poster Session)
Sponsored Session, Commercial Exhibition

July 2 (Thu)

General Assembly
Scientific Sessions (Lecture, Symposium, Workshop, Oral & Poster Session)
Sponsored Session, Commercial Exhibition
Banquet

July 3 (Fri)

Scientific Sessions (Lecture, Symposium, Workshop, Oral & Poster Session)
Sponsored Session, Commercial Exhibition
Closing Remarks

Commercial Exhibition will be held during the congress
All the abstract and slides of presentation will be provided in English.
Recommended language of poster is English.

as of January 21, 2026

Special Lecture (July 1 (Wed))

Feyen Bianca（J&J Innovative Medicine）

「Strategies to minimize the use of Non-human primates in drug development」

Educational Lecture (July 2 (Thu))

Saryu Goel (Former FDA reviewer)

「Personal perspectives on the FDA roadmap for the New Alternative Methodologies (NAMs) for nonclinical safety and efficacy assessment during drug development」

Symposium

Utilization of DDT/NAMs in Pharmaceutical Development in Japan: Current Status and Challenges
【KSOT-JSOT Joint Symposium】New developments in safety assessment using New Approached Methodologies (NAMs)
Non-clinical development of gene therapy and its toxicity to be considered
【HESI Joint Symposium】Global Trends in NAMs Toward Regulatory Acceptance
【SOT-JSOT Joint Symposium】Advances in Hepatotoxicity Research
Emerging Safety Biomarker Qualification Strategies Towards Regulatory Acceptance

Note: Only English sessions are listed above

Oral Sessions
Poster Sessions